Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Weekly Doxorubicin and Oral Topotecan for Patients With Relapsed or Refractory Small Cell Lung Cancer (SCLC)

NCT00856037 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT00856037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00856037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Weekly Doxorubicin and Oral Topotecan for Patients With Relapsed or Refractory Small Cell Lung Cancer (SCLC)
Lead sponsor
University of Nebraska
Phase
Phase 1
Overall status
Completed
Start date
February 2, 2009
Completion date
February 1, 2018
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent small cell lung carcinoma